
|Articles|February 15, 2003
In Brief
Atlanta-CIBA Vision Corp. executives have shuffled their roles as thecompany prepares for what manyin the industry expect to be another year of increased sales.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA approves carbachol–brimonidine eye drop for presbyopia following phase 3 BRIO trials
2
Opus Genetics launches phase 1/2 MERTK gene therapy trial
3
Eye exams could enable earlier detection of systemic disease
4
FDA approves NDA labeling supplement allowing re-administration of iDose TR
5



























